Diabetic nephropathy in type 1 diabetes: Has the outlook improved since the 1980s?

Diabetologia

Volumn 55, Issue 9, 2012, Pages 2301-2306

  Marshall, S M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Diabetic nephropathy; End stage renal disease; Microalbuminuria; Persistent proteinuria; Type 1 diabetes

Indexed keywords

ALBUMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; DIABETIC NEPHROPATHY; HUMAN; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; MICROALBUMINURIA; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVIEW; RISK ASSESSMENT; SURVIVAL TIME; UREMIA; URINARY EXCRETION;

DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; PROTEINURIA;

EID: 84866113394     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2606-1     Document Type: Review

References (33)

1. Andersen AR, Sandahl Christiansen J, Andersen LK, Kreiner S, Deckert T (1983) Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25:496-501
2. Borch-Johnsen K, Andersen PK, Deckert T (1985) The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 28:590-596
3. Mathiesen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T (1984) Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 26:406-410
4. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H (1982) Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1:1430-1432
5. Parving HH, Oxenboll B, Svendsen PA, Christiansen JS, Andersen AR (1982) Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urine albumin excretion. Acta Endocrinol 100:550-555
6. Mogensen CE, Christensen CK (1984) Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93
7. Keen H, Chlouverakis C (1963) An immunoassay method for urinary albumin at low concentrations. Lancet 2:913-914
8. Keen H, Chlouverakis C (1964) Urinary albumin excretion and diabetes mellitus. Lancet 2:1155-1156
9. DCCT/EDIC Research Group (2009) Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration. Arch Intern Med 169:1307-1316
10. Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard T (2006) The 30-year natural history of type 1 diabetes complications. Diabetes 55:1463-1469
11. Hovind P, Tarnow L, Rossing K et al (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258-1264
12. Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J, Linkoping Diabetes Complications Study (2004) Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetesthe Linkoping Diabetes Complications Study. Diabetologia 47:1266-1272
13. Finne P, Reunanen A, Stenman S, Groop PH, Gronhagen-Riska C (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294:1782-1787
14. Mollsten A, Svensson M, Waernbaum I et al (2010) Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study. Diabetes 59:1803-1808
15. Van Dijk PC, Jager KL, Stengel B, Grönhagen-Riska C, Feest TG, Briggs DJ (2005) Renal replacement therapy for diabetic end-stage renal disease: data from 10 registries in Europe (1991-2000). Kidney Int 67:1489-1499
16. DCCT/EDIC Research Group (2011) Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365:2366-2376
17. Astrup AS, Tarnow L, Rossing P, Pietraszek L, Riis Hansen P, Parving HH (2005) Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 68:1250-1257
18. Forsblom C, Harjutsalo V, Thorn LM et al (2011) Competing risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 22:537-544
19. Rosolowsky ET, Skupien J, Smiles A et al (2011) Risk for ESRD in type 1 diabetes remains high despite renoprotection. J Am Soc Nephrol 22:545-553
20. de Boer IH, Rue TC, Cleary PA et al (2011) Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort. Arch Intern Med 171:412-420
21. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS (2003) Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348:2285-2293
22. Hovind P, Rossing P, Tarnow L, Toft H, Parving J, Parving HH (2001) Remission of nephrotic-range albuminuria in type 1 diabetic patients. Diabetes Care 24:1972-1977
23. Molitch ME, Steffes M, Sun W et al (2010) Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 33:1536-1543
24. Costacou T, Ellis P, Fried L, Orchard TJ (2007) Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study. Am J Kidney Dis 50:721-732
25. Deckert T, Yokoyama H, Mathiesen ER et al (1996) Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ 312:871-874
26. Rossing P, Houggard P, Borch-Johnsen K, Parving HH (1996) Predictors of mortality in IDDM: 10 year observational follow-up study. BMJ 313:779-784
27. Groop PH, Thomas MC, Moran JL et al (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58:1651-1658
28. Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53:2312-2319
29. Earle K, Walker J, Hill C, Viberti G (1992) Familial clustering of cardiovascular disease in patients with insulin-dependent diabetes and nephropathy. N Engl J Med 326:673-677
30. Thorn LM, Forsblom C, Fagerudd J, Pettersson-Fernholm K, Kilpikari R, Groop PH, on behalf of the FinnDiane Study Group (2007) Clustering of risk factors in parents of patients with type 1 diabetes and nephropathy. Diabetes Care 30:1162-1167
31. Orchard TJ, Chang YF, Ferrell RE, Petro N, Ellis DE (2002) Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Kidney Int 62:963-970
32. Thomas MC, Groop PH, Tryggvason K (2012) Towards understanding the inherited susceptibility for nephropathy in diabetes. Curr Opin Nephrol Hypertens 21:195-202
33. Stehouwer CDA, Smulders YM (2006) Microalbuminuria and risk of cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 17:2106-2111